EcoDrugPlus

Dopamine Receptor D2a

Ensembl ID : ENSEEEG00000016166
Gene Symbol: DRD2A
2 Cross references
203 Possible Orthologues:

Dopamine Receptor D2b

Ensembl ID : ENSEEEG00000005115
Gene Symbol: DRD2B
4 Cross references
144 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSEEEG00000020964
Gene Symbol: DRD3
2 Cross references
202 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSEEEG00000009971
Gene Symbol: DRD4A
4 Cross references
176 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSEEEG00000000029
Gene Symbol: DRD4B
4 Cross references
176 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSEEEG00000021621
Gene Symbol: DRD5
4 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSEEEG00000002235
Gene Symbol: ENPP2
4 Cross references
226 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 1b

Ensembl ID : ENSEEEG00000024055
Gene Symbol: EGLN1B
4 Cross references
223 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSEEEG00000017053
Gene Symbol: EPAS1
4 Cross references
153 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSEEEG00000010407
Gene Symbol: EPAS1B
4 Cross references
214 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSEEEG00000013918
Gene Symbol: ECE1
4 Cross references
231 Possible Orthologues:

Endothelin Receptor Ba

Ensembl ID : ENSEEEG00000018922
Gene Symbol: EDNRBA
4 Cross references
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).